| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Geovax Labs, Inc. (GOVX) has 11 insiders with recent SEC Form 4 filings, including 11 buys and 0 sells. GOVX is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 185.5K | $246.7K | - | |
| Other | 70.0K | $93.1K | - | |
| VP | 70.0K | $93.1K | - | |
| CFO | 70.0K | $93.1K | - | |
| Dir | 21.4K | $28.5K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Oct 17, 2025 | Spencer John N Jr | Director | Buy | 10,000 | $0.55 | $5,498.00 | +87.7% | |
| Aug 7, 2025 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 1,107 | $0.67 | $741.69 | +46.4% | |
| Apr 10, 2025 | Sharkey John W. | VP, Business Development | Buy | 6,000 | $0.99 | $5,940.00 | +3,141% | |
| Apr 10, 2025 | Spencer John N Jr | Director | Buy | 10,000 | $0.98 | $9,800.00 | +713.3% | |
| Apr 1, 2025 | Dodd David A | President, CEO | Buy | 10,000 | $1.08 | $10,800.00 | +37.5% | |
| Mar 31, 2025 | Reynolds Mark | CFO | Buy | 6,800 | $1.08 | $7,343.32 | +94.3% | |
| Aug 9, 2024 | Dodd David A | President, CEO | Buy | 8,000 | $1.95 | $15,600.00 | +42.9% | |
| Feb 22, 2024 | Dodd David A | President, CEO | Buy | 8,729 | $2.27 | $19,781.16 | +42.8% | |
| Feb 7, 2024 | Reynolds Mark | CFO | Buy | 2,000 | $2.77 | $5,540.00 | +38.4% | |
| Dec 22, 2023 | McKee Kelly T. Jr. | Chief Medical Officer | Buy | 6,944 | $0.36 | $2,499.84 | +24.1% |